Skip to main content

URMC Logo

URMC / Research / Research@URMC
Researchers Look to Improve Late-Stage Liver Cancer Therapy

Researchers Look to Improve Late-Stage Liver Cancer Therapy

Scientists discovered a potential therapy for late-stage liver cancer based on earlier work showing that the androgen receptor (AR), the protein that makes testosterone functional, plays a major role in regulating this type of malignancy. 

7/26/2016
URMC Researchers Look for Better Treatments, Cures for Juvenile Arthritis

URMC Researchers Look for Better Treatments, Cures for Juvenile Arthritis

URMC Pediatric Rheumatologist Homaira Rahimi, M.D., M.S., discusses her research on juvenile arthritis during “Juvenile Arthritis Awareness Month”. According to the Centers for Disease Control, there are about 300,000 children living with some form of rheumatic disease in the US.  

7/25/2016
Award to Wilmot Oncologist Focuses on Ovarian Cancer Gene Target

Award to Wilmot Oncologist Focuses on Ovarian Cancer Gene Target

The Wilmot Cancer Institute’s Richard G. Moore, M.D., has identified a gene (HE4) that plays a major role in ovarian cancer, and he recently received a coveted Mary Kay Foundation cancer research award to develop a therapy that targets the gene.

7/19/2016
URMC Refractive Surgeon Selected for International Award

URMC Refractive Surgeon Selected for International Award

URMC's director of the Refractive Surgery Center in the Flaum Eye Institute, Scott MacRae, M.D., will be presented with the Jose I. Barraquer Award at the annual meeting of the American Academy of Ophthalmology in October. 

7/15/2016
Pancreatic Cancer Network Awards $2M to Wilmot Investigator

Pancreatic Cancer Network Awards $2M to Wilmot Investigator

The national Pancreatic Cancer Action Network (PANCAN) granted its most competitive award, for $2 million, to David C. Linehan, M.D., to support a large, multicenter clinical trial testing an immunotherapy in patients with metastatic pancreatic cancer.

7/13/2016